TrilliumBiO and LAM Foundation Partner to Boost LAM Awareness and Education

Hepatitis B is a viral infection that affects the liver and can cause both acute and chronic disease. The virus is transmitted through contact with infected blood or other body fluids. Laboratory testing plays a crucial role in diagnosing hepatitis B infection, monitoring disease progression, and determining the appropriate treatment strategy. Several blood tests are available to detect different markers of hepatitis B virus infection, each providing specific information about the stage and status of the disease.

The hepatitis B surface antigen test, commonly known as HBsAg, is typically the first screening test performed to detect active hepatitis B infection. When this antigen is present in the blood, it indicates that the person is currently infected with the virus and can potentially transmit it to others. If HBsAg remains positive for more than six months, the infection is considered chronic. Another important test is the hepatitis B surface antibody test, or anti-HBs, which detects antibodies produced in response to the surface antigen. The presence of these antibodies usually indicates recovery from infection or successful vaccination, providing immunity against future hepatitis B infections.

Additional tests include the hepatitis B core antibody tests, which come in two forms: IgM anti-HBc and total anti-HBc. The IgM antibody typically appears during acute infection, while total core antibody can indicate either current or past infection. The hepatitis B e antigen test and its corresponding antibody test help determine how actively the virus is replicating and the level of infectiousness. A positive e antigen usually suggests high viral replication and greater infectivity, while the presence of e antibody often indicates lower viral activity.

For patients with confirmed hepatitis B infection, healthcare providers may order a hepatitis B viral load test, also called HBV DNA quantification. This test measures the amount of viral genetic material in the blood and helps monitor disease activity and response to treatment. Liver function tests, including measurements of liver enzymes such as ALT and AST, are also commonly performed to assess liver damage. In chronic cases, additional tests may be recommended periodically to monitor the progression of liver disease and guide treatment decisions. Understanding these various test results helps healthcare providers develop personalized management plans for individuals affected by hepatitis B.